• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE Back to Search Results
Model Number 500101-001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Sepsis (2067); Multiple Organ Failure (3261)
Event Date 07/22/2020
Event Type  Death  
Manufacturer Narrative
The syncardia 70cc temporary total artificial heart (tah-t) is an implantable pulsatile biventricular replacement device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation systems.The syncardia 70cc tah-t is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.The syncardia tah-t system is intended for use inside and outside the hospital.Based on the provided information there is no evidence to indicate any device malfunctions or performance issues of the device that would impact the reported event.This issue will be monitored and trended as part of the customer experience process.Syncardia has completed its investigation and is closing this file.If new or additional information is received in the future, syncardia will file a follow-up mdr.(b)(4).
 
Event Description
The customer, a syncardia certified hospital, reported that the patient passed away on (b)(6) 2020.The customer reported the cause of death as multi organ system failure and sepsis with causes or contributing factors to the death as on-going multi-drug resistant infection, gi bleed despite being off anticoagulation for several months, chronic respiratory failure, kidney failure, acute decompensated heart failure, complicated by severe refractory septic shock.The customer indicated that the tah-t did not cause or contribute to the patient's outcome.The tah-t was not explanted and no autopsy was performed.No additional information has been provided at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T)
Type of Device
BIVENTRICULAR REPLACEMENT DEVICE
Manufacturer (Section D)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson, az
Manufacturer (Section G)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson, az
Manufacturer Contact
kerri hensley
1992 e. silverlake road
tucson, az 
5451234120
MDR Report Key10341469
MDR Text Key200960844
Report Number3003761017-2020-00165
Device Sequence Number1
Product Code LOZ
UDI-Device Identifier00858000003008
UDI-Public(01)00858000003008
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Nurse
Type of Report Initial
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2022
Device Model Number500101-001
Device Catalogue Number500101
Device Lot Number119215
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/22/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age47 YR
-
-